CPhI /P-MEC /ICSE India 2009, South Asia’s biggest and most comprehensive pharmaceutical event, will be held from December 1-3 2009 at the Bombay Exhibition Centre in Mumbai. This most eagerly awaited comprehensive international pharmaceutical event will enable visitors and participants to network and seize business opportunities that can be put into action and prepare you for the next era of growth. 

The event has 767 exhibitors from 20 countries & regions with pavilions from CCPIT, CCMHPIE & Pharmexcil. Also featuring at the event will be the P-MEC virtual factory and CPhI technology seminars, presented by the exhibiting companies. The exhibition will witness around 26,000 visitors from 70 plus countries. 

Also Read   Related Stories News Now - Airlines oppose new ground handling, refund norms - Retd HC judge to take charge as CLB Chairman on Friday - Tata Communications, Qatari co in pact for undersea cable - Govt seeks to restrict export of dual-use items - Nalco announces cash incentive for fly ash disposal - Lending rates still sticky and non-transparent: Subbarao

Also Read   Related Stories News Now - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report More

Manufacturers of active pharmaceutical ingredients, excipients, natural extracts as well as experts in custom manufacturing will be present at CPhI India. P-MEC India will showcase companies offering pharmaceutical manufacturing technology and solutions. ICSE (The International Contract Service Expo) pavilion is dedicated to the contract services part of the pharmaceutical manufacturing process that will feature exhibitors who are looking at pharmaceutical outsourcing. This year, UBM is proud to introduce BioPh India: Bio-Solutions for Pharma - Hosting such an event alongside established events like CPhI and P-MEC, offers unrivalled networking and commercial opportunities, creating a perfect synergy in the world of drug research and manufacturing. 

CPhI / P-MEC / ICSE India 2009, will throw open its doors to the rapidly expanding Indian, South Asian and world pharmaceutical markets, presenting exceptional and countless opportunities in pharmaceutical manufacturing, procurement and new technologies. India’s domestic potential including the untapped rural markets alone, makes it a fascinating market for many in the pharmaceutical industry. Add the explosive economic growth of the region and it becomes obvious why buyers and sellers of pharmaceutical products consider CPhI / P-MEC / ICSE India an event not to be missed. 

Concurrent events - The Government of India, Ministry of Chemicals and Fertilisers, Department of Pharmaceuticals, is organising India Pharma Summit 2009, scheduled on November 30, 2009 at Nehru Center, Worli, Mumbai. The Theme of this summit is: - India your partner in Pharma. This Summit will identify opportunities, challenges and create a roadmap to achieve consistent growth. The summit will cover topics like “India Pharma - Status and Opportunities for Production, Investment & Trade,” Opportunities and Challenges in R & D, Clinical Trials, Pharma Education and Industry Academia Partnership” and Vision – “India the Global Partner.” 

A Bio-similars India Conference will be taking place alongside CPhI India 2009 at the Bombay Exhibition Centre December 1 and 2. Biosimilars India 2009 consists of 3 halfday conference modules, each designed to provide you with solutions to the strategic issues facing the growing Indian biosimilars market. The conference will cover Biosimilars – Market Opportunities, Regulatory Compliance and Cost effective Production. Hear from an exceptional line-up of leading experts including:- Dr. Arumugam Muruganandam, Senior Scientific Manager, Research & Development, Biocon,Dr. Harvinder Popli, Director and Head In- Licensing, Ranbaxy Labs,Mr. K V Subramaniam, President & CEO, Reliance Life Sciences,Mr. Vijay Kshirsagar, Executive Vice President, Corporate Quality Assurance & Regulatory Affairs, Unichem Laboratories, Dr. Rangarajan Subramanian, Senior Vice President, Quality, Glenmark Generics ,Mr. Dhananjay Patankar, Director, Intas Biopharma.

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report

Tags : Global pharma majors   Read Business news in  Advertisements -  Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol. -  Journey on, We are by Your Side. Click here to know more -  2 Lac Apartments, 1 Lac House / Plots. Click here -  Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol. -  Watch The Film Here. Click here to know more.. -  Leader in Passenger Car & Automobile Tyres. Click here -  1 billion in saving for Unilever without any tangles. -  Learn How One City is Running on FOOD SCRAPS. -  Helping doctors detect diseases earlier, saving costs & extending lives. -  36 Lakhs can get you a pool of Luxuries. Click here -  Which is the best plan for your daughter -  Check out the TRUE COLOURS of your Stocks, Now for FREE! -  One of the leading business schools in the world.Know More